Abstract:Background: Conventional approaches to drug discovery are often characterized by lengthy and costly processes. To expedite the discovery of new drugs, the integration of artificial intelligence (AI) in predicting drug-target binding affinity (DTA) has emerged as a crucial approach. Despite the proliferation of deep learning methods for DTA prediction, many of these methods primarily concentrate on the amino acid sequence of proteins. Yet, the interactions between drug compounds and targets occur within distinct segments within the protein structures, whereas the primary sequence primarily captures global protein features. Consequently, it falls short of fully elucidating the intricate relationship between drugs and their respective targets. Objective: This study aims to employ advanced deep-learning techniques to forecast DTA while incorporating information about the secondary structure of proteins. Methods: In our research, both the primary sequence of protein and the secondary structure of protein were leveraged for protein representation. While the primary sequence played the role of the overarching feature, the secondary structure was employed as the localized feature. Convolutional neural networks and graph neural networks were utilized to independently model the intricate features of target proteins and drug compounds. This approach enhanced our ability to capture drugtarget interactions more effectively Results: We have introduced a novel method for predicting DTA. In comparison to DeepDTA, our approach demonstrates significant enhancements, achieving a 3.9% increase in the Concordance Index (CI) and a remarkable 34% reduction in Mean Squared Error (MSE) when evaluated on the KIBA dataset. Conclusion: In conclusion, our results unequivocally demonstrate that augmenting DTA prediction with the inclusion of the protein's secondary structure as a localized feature yields significantly improved accuracy compared to relying solely on the primary structure.

Sequence-based drug-target affinity prediction using weighted graph neural networks

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

A survey of drug-target interaction and affinity prediction methods via graph neural networks

Drug-Target Affinity Prediction Based on Improved GraphDTA

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

Drug–target affinity prediction with extended graph learning-convolutional networks

Predicting Drug-Target Affinity by Learning Protein Knowledge From Biological Networks

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM

SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction

EmbedDTI: Enhancing the Molecular Representations via Sequence Embedding and Graph Convolutional Network for the Prediction of Drug-Target Interaction

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Fusing Sequence and Structural Knowledge by Heterogeneous Models to Accurately and Interpretively Predict Drug–Target Affinity

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

GraphDTA: predicting drug-target binding affinity with graph neural networks

Drug-target Affinity Prediction by Molecule Secondary Structure Representation Network

NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction

SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network

SS-GNN: A Simple-Structured Graph Neural Network for Affinity Prediction

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

GEFormerDTA: drug target affinity prediction based on transformer graph for early fusion